NYSE - Nasdaq Real Time Price USD

Kenvue Inc. (KVUE)

Compare
19.80
-0.94
(-4.53%)
At close: 4:00:02 PM EST
19.75
-0.05
(-0.25%)
After hours: 5:13:04 PM EST
Loading Chart for KVUE
DELL
  • Previous Close 20.74
  • Open 20.53
  • Bid 19.69 x 2900
  • Ask 20.60 x 2900
  • Day's Range 19.75 - 21.10
  • 52 Week Range 17.67 - 24.46
  • Volume 23,608,033
  • Avg. Volume 12,623,123
  • Market Cap (intraday) 37.962B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 36.00
  • EPS (TTM) 0.55
  • Earnings Date Feb 6, 2025
  • Forward Dividend & Yield 0.82 (3.95%)
  • Ex-Dividend Date Feb 12, 2025
  • 1y Target Est 24.44

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

www.kenvue.com

22,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KVUE

View More

Performance Overview: KVUE

Trailing total returns as of 2/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

KVUE
7.26%
S&P 500
3.43%

1-Year Return

KVUE
0.05%
S&P 500
22.80%

3-Year Return

KVUE
22.44%
S&P 500
35.17%

5-Year Return

KVUE
22.44%
S&P 500
81.83%

Compare To: KVUE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KVUE

View More

Valuation Measures

As of 2/5/2025
  • Market Cap

    39.76B

  • Enterprise Value

    47.53B

  • Trailing P/E

    37.71

  • Forward P/E

    17.15

  • PEG Ratio (5yr expected)

    1.93

  • Price/Sales (ttm)

    2.58

  • Price/Book (mrq)

    3.74

  • Enterprise Value/Revenue

    3.07

  • Enterprise Value/EBITDA

    18.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.88%

  • Return on Assets (ttm)

    6.50%

  • Return on Equity (ttm)

    9.88%

  • Revenue (ttm)

    15.46B

  • Net Income Avi to Common (ttm)

    1.06B

  • Diluted EPS (ttm)

    0.55

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.06B

  • Total Debt/Equity (mrq)

    82.93%

  • Levered Free Cash Flow (ttm)

    1.52B

Research Analysis: KVUE

View More

People Also Watch